Latest News about JAZZ
Recent news which mentions JAZZ
2 Dirt Cheap Growth Stocks to Buy and Hold for Years
November 18, 2022
From Motley Fool
Is Axsome Therapeutics Stock a Buy Now?
November 11, 2022
From Motley Fool
What 5 Analyst Ratings Have To Say About Jazz Pharmaceuticals
November 10, 2022
Tickers
JAZZ
From Benzinga
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance
November 10, 2022
Tickers
JAZZ
From Benzinga
Why Axsome Therapeutics Stock Slipped Today
November 07, 2022
From Motley Fool
3 Top Healthcare Stocks to Buy for November
November 04, 2022
From Motley Fool
Why Shares of Zymeworks Rose 12.18% on Monday
October 31, 2022
From Motley Fool
2 Marijuana Stocks That Are Set for a Comeback
October 28, 2022
From Motley Fool
Jazz Pharma's Zepzelca For Lung Cancer Flunked Confirmatory Trial, But FDA Will Not Pull Accelerated Approval
October 26, 2022
Tickers
JAZZ
From Benzinga
Analyst Moves To Sidelines After Jazz Pharma Deal Shifts Zymeworks To Early Stage Pipeline
October 21, 2022
From Benzinga
Why Zymeworks Stock Is Soaring Today
October 19, 2022
From Motley Fool
Why Is Zymeworks (ZYME) Stock Up Today?
October 19, 2022
From InvestorPlace
Jazz Obtains Exclusive Rights To Zymeworks' Cancer Candidate In Almost $2B Biobuck Deal
October 19, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2022
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
October 18, 2022
From Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
3 Top Marijuana Stocks to Buy for the Long Haul
October 07, 2022
From Motley Fool
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
From Motley Fool
3 Healthcare Stocks That Could Make You Richer
October 05, 2022
From Motley Fool
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
October 02, 2022
From Motley Fool
Japan Is Inching Toward Cannabis Legalization, Companies Like This One Could Benefit
September 29, 2022
Tickers
JAZZ
From Benzinga
UBS Slashes PT On This Stock By Over 89%? Plus Evercore ISI Group Predicts $150 For First Solar
September 29, 2022
From Benzinga
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
September 23, 2022
From Motley Fool
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
September 22, 2022
From Motley Fool
5 Analysts Have This to Say About Jazz Pharmaceuticals
September 21, 2022
Tickers
JAZZ
From Benzinga
Is It Too Late to Buy Axsome Therapeutics Stock?
September 17, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
From InvestorPlace
3 Top Pot Stocks to Watch in September
September 15, 2022
From Motley Fool
Is Axsome Therapeutics a Buy?
September 09, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
